Department of Health & Social Care’s MedTech Strategy One Year on Welcomed by AXREM


In February 2023, The Department of Health & Social Care published the government’s inaugural MedTech strategy. This set out how, over the next 5 to 10 years, they will ensure the health and social care system can reliably access safe, effective and innovative technologies. These technologies will enable the delivery of high-quality care, outstanding patient safety and excellent health outcomes, while making the best use of taxpayer money.

One year into delivery of the MedTech strategy, the DHSC have today published an update on their achievements towards establishing an innovation pathway, to realise their vision of right product, right price, right place.

The DHSC recognise that MedTech is integral to tackling the nation’s major health challenges, with the ability to transform care and improve both productivity and patient outcomes. It plays an important role at each point in a patient’s care pathway from prevention through to diagnostics, treatment and aftercare. AXREM members products and services are present on most diagnostic and care pathways so we welcomed the MedTech Strategy when it was published last year and we welcome the update and focus on medical technology.

Jeevan Gunaratnam, AXREM Chair said upon reading the publication “I am delighted to welcome the DHSC MedTech Strategy One Year On publication and release of the associated MedTech Innovation Classification Framework.

Through our work with David Lawson and the wider DHSC team, supported by Lord Markham and the Rt. Hon. Andrew Stephenson, AXREM has contributed to improving the landscape for the adoption of innovative medical technology, at pace and at scale, to positively impact patient care.

There has never been a more crucial time for industry to partner with key stakeholders, including Government and the NHS, to drive the improved outcomes, productivity and efficiencies needed to deliver a world-class healthcare service. AXREM is proud to play a key role in supporting this important work”.

Sally Edgington, AXREM Chief Executive Officer said “I have been encouraged by the engagement AXREM has seen with David Lawson and his team to help deliver and develop the MedTech strategy, AXREM is named as one of the key stakeholders to the Department of Health and Social Care’s plans in the report and I look forward to further building on the engagement and collaboration we have with the DHSC.

I am pleased to see the progress that has been made one year on and there being more focus on diagnostics than ever before, the recognition from government that the innovations and technologies that AXREM members provide are key to deliver the strategy and ensuring patients receive the quickest and most accurate diagnosis and care”.

Read the Medical technology strategy: one year on in full here: